US FDA grants tentative approval for Sun's generic Aricept

30 Nov 2010

1

Mumbai: Sun Pharmaceutical  today said that ther US FDA has granted a tentative approval for an abbreviated new drug application to market its generic version of Aricept, donepezil hydrochloride tablets, used in the treatment of dementia.

These generic donepezil hydrochloride tablets, equivalent to Eisai's aricept tablets, include two strengths: 5 mg and 10 mg, the annual sales of which  in the US is approximately $2.5 billion.

Donepezil hydrochloride tablets are indicated in the treatment of dementia of the Alzheimer's type.

Efficiency has been demonstrated in patients with mild, moderate and severe Alzheimer's disease, Sun said in a statement.

Aricept is a registered trademark of Japan's Eisai co. Ltd.

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers